NCT02296463 - A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

April 30, 2016

Conditions

Respiratory Synctial Virus

Interventions

BIOLOGICAL

RSV F Vaccine with adjuvant (0.5mL injection)

BIOLOGICAL

RSV F Vaccine (0.5mL injection)

BIOLOGICAL

Hepatitis A Vaccine (0.5mL injection)

BIOLOGICAL

Placebo (0.5mL injection)

Trial Locations (4)

University of Calgary, Alberta Children's Hospital, Calgary

Dalhousie University, IWK Health Centre- Canadian Center for Vaccinology, Halifax

Aggarwal and Associates, Brampton

Medicore Research, Inc, Greater Sudbury